A group of us @citeline and @norstella are taking part in #RaceforLife in memory of our colleague Maureen Kenny - @scripregmaureen - and we would love to raise as much as possible for cancer research... https://t.co/RoQujzw6VJ
We're hiring! We need a US reporter with experience covering #biopharma to join our global team of expert journalists at @PharmaScrip. If you can bring expert analysis to industry events and trends, apply here: https://t.co/GrZhx3FWXb
Are you our new Features Writer?
Know someone who might be?
Find our latest available role and apply now: https://t.co/PPtZsxU1nH
#recruuiting#writer#jobsearch#jobs
We're hiring! Do you know about US drug pricing, reimbursement and #pharma market #strategy? We're looking for a new team member to provide regular updates and analysis for our pharma industry clients. Check out the details below https://t.co/JaKUjefJam
Journalists! We are looking for an enterprising investigative reporter to build a beat around drug pricing, reimbursement and market strategy for subscribers to @PharmaScrip's analytical news and insights service (part of the @pharma_intell suite)
https://t.co/S1JZdophCv
We're hiring on @PharmaScrip and @INVIVOnow for great journalists to dig deep into #pharma issues like drug pricing, business strategy and scientific innovation. Apply here: https://t.co/S1JZdophCv & https://t.co/lBPKNbTq6n
A very warm @PharmaScrip welcome to our new colleague @Ayisha_Sharma97! Great to have you on our team of biopharma journalists Ayisha. Here's her dive into base editing, a next-big-thing in gene editing.
https://t.co/mMp6eiEJJN
Are you an expert in US pharma pricing, reimbursement & markets? Can you write compelling news/analysis for pharma decision makers? We want to recruit a journalist to build a beat around commercial strategy, drug pricing and the payer environment for Scrip https://t.co/gtAjymQzP7
There's still time to sign up for the @Pharma_Intell three-part panel discussion series on cell and gene therapies. First one starts in 90 mins, on novel development strategies for clinical trials https://t.co/RCNdLdOCxw
Lot of plain speaking here by NIH chief & Hamburg. WHO efforts/role valuable/critical but very difficult for it to be driver of big policy changes & it shouldn’t pretend to be a regulatory agency https://t.co/2VhMvtD89b
Check out our new 2021 line-up of 30 rising leaders in pharma, biotech & health tech just published in @INVIVOnow https://t.co/PM42FSMyOQ @Pharma_Intell
Join @INVIVOnow on May 18 for a panel discussion on leadership in times of uncertainty and upheaval, with Mark Reisenauer from @AstellasUS, Albireo's Ron Cooper, Semi Trotto from Thrive Earlier Detection and Catherine Owen, @bmsnews https://t.co/FvcbkAMzvt